About SARInet plus
SARInet plus is a collaboration coordinated by the Pan American Health Organization/World Health Organization (PAHO/WHO) of professionals from hospitals, laboratories, health organizations and other institutions and networks that have participated in the surveillance of Acute Respiratory Infections Serious (SARI) in the Americas.
Created in 2014, SARInet has been a key element in the scientific research of different viral infections (like Influenza) and includes members from countries across the Americas such as Antigua and Barbuda, Argentina, Bahamas, Barbados, Belize, Bolivia, Brazil, Canada, Chile, Colombia, Costa Rica, Cuba , Dominica, Dominican Republic, Ecuador, El Salvador, Grenada, Guatemala, Guyana, Haiti, Honduras, Jamaica, Mexico, Nicaragua, Panama, Paraguay, Peru, Saint Lucia, St. Vincent and the Grenadines, St. Kitts and Nevis, Suriname, Trinidad and Tobago, United States of America, Uruguay and Venezuela.
Three different stages can be distinguished in the evolution of SARInet:
After the H1N1 influenza pandemic the countries of the Americas felt the need to develop and implemented SARI surveillance methodologies in sentinel hospitals in the region. The efforts and the results achieved made it clear that there was a need for the implementation of continuous research and surveillance.
SARInet was created in 2014 as a tool to maintain coordinated collaboration among professionals from hospitals, laboratories, health organizations and networks that have participated in SARI and ILI surveillance. All the work done throughout the years proved to be a massive advantage on how to deal with the SAR-CoV2 pandemic that started in 2019.
After eight years of continuous work and achieving several of its initial objectives, SARInet decided to expand itself. As a result, it was agreed, by the members, to rename the network SARInet plus in order to incorporate the surveillance of other respiratory viruses with epidemic and pandemic potential. This came from the understanding that its detection, monitoring, and evaluation is especially relevant to strengthening respiratory pathogen surveillance systems, human-animal interface and clinical management in the Americas.
Lead in the Region of the Americas the cooperation, exchange of knowledge and experiences related to influenza and other respiratory viruses with epidemic and pandemic potential.
To be a network for dialogue, opinion and participation, committed to the generation of scientific evidence that influences the health policies of the countries of the Region aimed at the implementation of measures to prevent, control and reduce the burden of viral respiratory infections.